Research ArticleClinical Studies

Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer

ALBERTO MENEGUZZO, ANNALISA LAZZAROTTO and MAURO ALAIBAC
In Vivo January 2020, 34 (1) 441-445; DOI: https://doi.org/10.21873/invivo.11793

Article Information

vol. 34 no. 1 441-445
DOI 
https://doi.org/10.21873/invivo.11793
PubMed 
31882511
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received August 29, 2019
  • Revision received September 27, 2019
  • Accepted September 30, 2019
  • Published online December 27, 2019.
Copyright & Usage 
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. ALBERTO MENEGUZZO,
  2. ANNALISA LAZZAROTTO and
  3. MAURO ALAIBAC⇑
  1. Unit of Dermatology, University of Padua, Padua, Italy
  1. Correspondence to: Mauro Alaibac, Unit of Dermatology, University of Padua, via Gallucci 4, 35128 Padua, Italy. Tel: +39 0498212901, e-mail: mauro.alaibac{at}unipd.it
View Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Eruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer
ALBERTO MENEGUZZO, ANNALISA LAZZAROTTO, MAURO ALAIBAC
In Vivo Jan 2020, 34 (1) 441-445; DOI: 10.21873/invivo.11793
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords